ImmunoGen, Inc. (IMGN) in Focus: Stock Rallies 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:44AM CDT
ImmunoGen, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.
Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 % - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 7:44AM CDT
Kythera Biopharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences
PR Newswire - Mon Apr 14, 8:00AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89% to 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the 10 sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has lost 4.46% in the last one month. Investor-Edge has initiated coverage on the following equities: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Incyte Corp. Ltd (NASDAQ: INCY), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) and Aastrom Biosciences Inc. (NASDAQ: ASTM). Free technical research on ALXN, INCY, MACK and ASTM can be downloaded upon signing up at:
Baxano Surgical, Inc. (BAXS) in Focus: Stock up 10.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:44AM CDT
Baxano Surgical, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Rallies 11.06% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 11% on the day.
Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that the independent Data and Safety Monitoring Board (DSMB) for the company's ixCELL-DCM Phase 2b clinical trial has recommended continuing the study without modification as planned following an interim review of unblinded safety data from the trial.
RadNet, Inc. (RDNT) in Focus: Stock Surges 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:44AM CDT
RadNet, Inc. was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:44AM CDT
Questcor Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares shoot up nearly 19% on the day.
Strength Seen in MannKind Corp. (MNKD), Stock Shoots up 74% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 7:44AM CDT
MannKind Corp. was a big mover last session, as the company saw its shares surge a whopping 73.9% on the day.
Durata Therapeutics (DRTX) in Focus: Stock Up 5.64% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 7:44AM CDT
Durata Therapeutics, Inc. was a big mover last session, as the company saw its shares jump nearly 6% on the day.
Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer
GlobeNewswire - Tue Apr 01, 8:25AM CDT
Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced the appointments of Ross Tubo, PhD, as chief scientific officer and David Recker, MD, FACR, FACP, as chief medical officer of Aastrom.
Cara Therapeutics Inc. (CARA) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:57AM CDT
Cara Therapeutics Inc. was a big mover last session, as the company saw its shares rise nearly 13% on the day.
Dyax Corp. (DYAX) in Focus: Stock Up 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:44AM CDT
Dyax Corp. was a big mover last session, as the company saw its shares rally nearly 6% on the day.
Traders Get Bullish on Shares of Aastrom Biosciences, Shares Up 9.6% (ASTM)
Comtex SmarTrend(R) - Mon Mar 31, 12:45PM CDT
Aastrom Biosciences (NASDAQ:ASTM) is one of today's best performing low-priced stocks, up 9.6% to $4.45 on 1.4x average daily volume. Aastrom Biosciences has traded 695,000 shares thus far today, vs. average volume of 505,000 shares per day. The stock has outperformed the Dow (9.6% to the Dow's 0.8%) and outperformed the S&P 500 (9.6% to the S&P's 0.8%) during today's trading.
Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.
MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:44AM CDT
MEI Pharma, Inc. was a big mover last session, as the company saw its shares rise over 12% on the day.
Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences
PR Newswire - Tue Mar 25, 10:25AM CDT
On Monday, March 24, 2014, the NASDAQ Composite ended at 4,226.39, down 1.18%, the Dow Jones Industrial Average declined 0.16% to 16,276.69, and the S&P 500 closed at 1,857.44, down 0.49%. The losses were broad based as 8 out of 10 sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 666.18, down 1.41%, and the same has fallen by 2.67% in the last one month. Investor-Edge has initiated coverage on the following equities: Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Incyte Corp. Ltd (NASDAQ: INCY) and Aastrom Biosciences Inc. (NASDAQ: ASTM). Free technical research on MACK, ALXN, INCY and ASTM can be downloaded upon signing up at:
Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synta, Ziopharm, Aastrom, Agios, and OncoMed
PR Newswire - Tue Mar 25, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Synta Pharmaceuticals Corp. (NASDAQ: SNTA), ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), Aastrom Biosciences, Inc. (NASDAQ: ASTM), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), and OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Zynga Shares Drop as King Digital Gets Ready for IPO Filing; Twitter User Base Growth May be Slowing Down
ACCESSWIRE - Mon Mar 24, 11:24PM CDT
Twitter, Inc. (NYSE: TWTR) - For an in-depth report on Twitter, Inc. follow: www.BullTrends.com/stockquote/TWTR
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 24, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: